Cytokine X-anti-target B (Kanaph Therapeutics)

N/A

Report date: 2025/03/18 18:14:24

Base Information

Drug NameCytokine X-anti-target B (Kanaph Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionCytokine receptors modulators

TargetsCytokine receptors

Therapy Area/IndicationsHematologic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKanaph Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKanaph Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHematologic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A